{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:36:59Z","timestamp":1791405419892,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2010.12.062","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T09:11:54Z","timestamp":1294132314000},"page":"6802-6809","source":"Crossref","is-referenced-by-count":24,"title":["Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge"],"prefix":"10.1016","volume":"29","author":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"November (Suppl. 4)","key":"10.1016\/j.vaccine.2010.12.062_bib0005","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0015","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0050003","article-title":"Plague: past present, and future","volume":"5","author":"Stenseth","year":"2008","journal-title":"PLoS Med"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2010.12.062_bib0020","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0021-8707(70)90061-4","article-title":"Allergic reactions due to plague vaccine","volume":"46","author":"Reisman","year":"1970","journal-title":"J Allergy"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2010.12.062_bib0030","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/129.Supplement_1.S19","article-title":"Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine","volume":"129","author":"Marshall","year":"1974","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.062_bib0035","first-page":"753","article-title":"Potency of killed plague vaccines prepared from avirulent Yersinia pestis","volume":"58","author":"Williams","year":"1980","journal-title":"Bull World Health Organ"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2010.12.062_bib0040","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"issue":"August (28)","key":"10.1016\/j.vaccine.2010.12.062_bib0045","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.12.062_bib0050","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2010.12.062_bib0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"December (3\u20134)","key":"10.1016\/j.vaccine.2010.12.062_bib0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2010.12.062_bib0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"October (4\u20135)","key":"10.1016\/j.vaccine.2010.12.062_bib0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"March (16)","key":"10.1016\/j.vaccine.2010.12.062_bib0075","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2004.10.025","article-title":"Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens","volume":"23","author":"Glynn","year":"2005","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.12.062_bib0080","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens","volume":"73","author":"Glynn","year":"2005","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.062_bib0085","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2010.12.062_bib0090","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2010.12.062_bib0095","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.vaccine.2008.01.024","article-title":"Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb\/C mice","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2010.12.062_bib0100","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2009.10.059","article-title":"Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2010.12.062_bib0105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2003.09.020","article-title":"Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen","volume":"22","author":"Garmory","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.062_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/0-306-48416-1_84","article-title":"Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague","volume":"529","author":"Grosfeld","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect Immun"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2010.12.062_bib0120","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.vaccine.2010.02.022","article-title":"A parenteral DNA vaccine protects against pneumonic plague","volume":"28","author":"Yamanaka","year":"2010","journal-title":"Vaccine"},{"issue":"October","key":"10.1016\/j.vaccine.2010.12.062_bib0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.12.062_bib0130","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.062_bib0135","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.062_bib0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.062_bib0145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/978-0-387-72124-8_35","article-title":"Cell-mediated defense against Yersinia pestis infection","volume":"603","author":"Smiley","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2010.12.062_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Exp Rev Vaccines"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.062_bib0155","first-page":"1045","article-title":"Mechanisms of long and short term immunity to plague","volume":"34","author":"Wake","year":"1978","journal-title":"Immunology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.062_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2010.12.062_bib0165","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1016\/j.vaccine.2007.08.021","article-title":"Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity","volume":"25","author":"Eyles","year":"2007","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.062_bib0170","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2353\/ajpath.2009.071168","article-title":"Pneumonic plague pathogenesis and immunity in Brown Norway rats","volume":"174","author":"Anderson","year":"2009","journal-title":"Am J Pathol"},{"issue":"June (5371)","key":"10.1016\/j.vaccine.2010.12.062_bib0175","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.280.5371.1875","article-title":"Progress in the development of an HIV-1 vaccine","volume":"280","author":"Letvin","year":"1998","journal-title":"Science (New York, NY)"},{"issue":"November","key":"10.1016\/j.vaccine.2010.12.062_bib0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.1995.tb44732.x","article-title":"DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response","volume":"772","author":"Whalen","year":"1995","journal-title":"Ann NY Acad Sci"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0185","first-page":"55","article-title":"DNA vaccines: what can we expect?","volume":"5","author":"Siegrist","year":"1996","journal-title":"Infect Agents Dis"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.12.062_bib0190","first-page":"173","article-title":"DNA vaccination for cancer treatment","volume":"2","author":"Spooner","year":"1995","journal-title":"Gene Ther"},{"issue":"July (Web Server issue)","key":"10.1016\/j.vaccine.2010.12.062_bib0195","doi-asserted-by":"crossref","first-page":"W180","DOI":"10.1093\/nar\/gki479","article-title":"PREDBALB\/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB\/c mouse","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-1759(90)90464-7","article-title":"Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay","volume":"128","author":"Taguchi","year":"1990","journal-title":"J Immunol methods"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-1759(94)00327-S","article-title":"Quantification of antigen specific CD8+ T cells using an ELISPOT assay","volume":"181","author":"Miyahira","year":"1995","journal-title":"J Immunol Methods"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-1759(97)00033-1","article-title":"Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR","volume":"204","author":"Favre","year":"1997","journal-title":"J Immunol Methods"},{"issue":"April (1\u20132)","key":"10.1016\/j.vaccine.2010.12.062_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(00)00153-8","article-title":"Intracellular staining for TNF and IFN-gamma detects different frequencies of antigen-specific CD8(+) T cells","volume":"238","author":"Badovinac","year":"2000","journal-title":"J Immunol Methods"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.12.062_bib0220","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2010.12.062_bib0225","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1128\/JVI.78.22.12471-12479.2004","article-title":"Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4","volume":"78","author":"McCurdy","year":"2004","journal-title":"J Virol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2010.12.062_bib0230","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.12.062_bib0235","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.12.062_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.iy.11.040193.001021","article-title":"Immunity to intracellular bacteria","volume":"11","author":"Kaufmann","year":"1993","journal-title":"Annu Rev Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.062_bib0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2004.07.013","article-title":"Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae","volume":"114","author":"Pujol","year":"2005","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"February (Pt 1)","key":"10.1016\/j.vaccine.2010.12.062_bib0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1042\/bst0310104","article-title":"Yersinia pestis and plague","volume":"31","author":"Titball","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"October","key":"10.1016\/j.vaccine.2010.12.062_bib0255","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.83.4.348","article-title":"The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague","volume":"83","author":"Cavanaugh","year":"1959","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/135.1.67","article-title":"Cellular immune response to Yersinia pestis modulated by product(s) from thymus-derived lymphocytes","volume":"135","author":"Wong","year":"1977","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.062_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.12.062_bib0270","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1128\/IAI.73.11.7142-7150.2005","article-title":"Pathogenesis of Yersinia pestis infection in BALB\/c mice: effects on host macrophages and neutrophils","volume":"73","author":"Lukaszewski","year":"2005","journal-title":"Infect Immun"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2010.12.062_bib0275","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1073\/pnas.0502849102","article-title":"Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus","volume":"102","author":"Pujol","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"January (6)","key":"10.1016\/j.vaccine.2010.12.062_bib0280","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2006.09.052","article-title":"Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague","volume":"25","author":"Williamson","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:41:30Z","timestamp":1685904090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":56,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X10018359"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}